Company research / PURE
Pure Bioscience, Inc. (PURE)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Jul 31
For the year ended 2025-07-31, Pure Bioscience, Inc. reported revenue of $2.20M. Revenue grew 12.2% from the prior annual period. Over the twelve months to 2026-04-30, revenue was $2.42M.
Key ratios (year ended 2025-07-31)
59.2%
Gross margin
-103.2%
Operating margin
-108.9%
Net margin
12.2%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.